scholarly journals Good survival outcome of metastatic SDH-deficient gastrointestinal stromal tumors harboring SDHA mutations

2014 ◽  
Vol 17 (5) ◽  
pp. 391-395 ◽  
Author(s):  
Maria A. Pantaleo ◽  
Cristian Lolli ◽  
Margherita Nannini ◽  
Annalisa Astolfi ◽  
Valentina Indio ◽  
...  
2017 ◽  
Vol 40 (4) ◽  
pp. 399-404 ◽  
Author(s):  
Helmneh M. Sineshaw ◽  
Ahmedin Jemal ◽  
Chun Chieh Lin ◽  
LaMar S. McGinnis ◽  
Elizabeth M. Ward

2001 ◽  
Vol 120 (5) ◽  
pp. A401-A401 ◽  
Author(s):  
D EFRON ◽  
K LILLEMOE ◽  
J CAMERON ◽  
S TIERNEY ◽  
S ABRAHAM ◽  
...  

2018 ◽  
pp. 3-14

Gastrointestinal stromal tumors (GIST) are the most common mesenchymal tumors of the digestive tract (1%). These tumors express the CD 117 in 95% of cases. The stomach is the preferential localization (70%). Diagnosis is difficult and sometimes late. Progress of imaging has greatly improved the management and the prognosis. Computed tomography (CT) is the gold standard for diagnosis, staging, and treatment follow-up. The increasing recognition of GIST’s histopathology and the prolonged survival revealed some suggestive imaging aspects. Key words: gastro-intestinal stromal tumors; computed tomography; diagnosis


Sign in / Sign up

Export Citation Format

Share Document